Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Improved national Croatian diagnostic and therapeutic guidelines for premalignant lesions of the uterine cervix with some cost-benefit aspects (CROSBI ID 97854)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Ljubojević, Nikola ; Babić, Silva ; Audy-Jurković, Silvana ; Ovanin-Rakić, Ana ; Jukić, Stanko ; Babić, Damir ; Grubišić, Goran ; Radaković, Branko ; Ljubojević-Grgec, Dragana Improved national Croatian diagnostic and therapeutic guidelines for premalignant lesions of the uterine cervix with some cost-benefit aspects // Collegium antropologicum, 25 (2001), 2; 467-474-x

Podaci o odgovornosti

Ljubojević, Nikola ; Babić, Silva ; Audy-Jurković, Silvana ; Ovanin-Rakić, Ana ; Jukić, Stanko ; Babić, Damir ; Grubišić, Goran ; Radaković, Branko ; Ljubojević-Grgec, Dragana

engleski

Improved national Croatian diagnostic and therapeutic guidelines for premalignant lesions of the uterine cervix with some cost-benefit aspects

The national Croatian improved diagnostic and therapeutic guidelines for premalignant lesions of the uterine cervix are presented: for atypical squamous cells of undetermined significance (ASCUS), for cervical intraepithelial neoplasia (CIN I, CIN II CIN III) and for microcarcinoma (FIGO grade Ia1). Separately are presented the guidelines for abnormal glandular epithelium: atypical glandular cells of undetermined significance (AGCUS) and cervical glandular intraepithelial neoplasia (CGIN). The guidelines are created according to the guidelines of the FIGO. Improved diagnostic and therapeutic guidelines was presented and accepted at the Symposium of the Croatian Society for Colposcopy and Cervical Pathology and of the Croatian Society of Gynecologists and Obstetricians of the Croatian Medical Association, held on November 25th 2000. There are presented the chief differences and the some cost-benefit aspects between the guidelines before and the new one.

CIN; ASCUS; FIGO; guidelines

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

25 (2)

2001.

467-474-x

objavljeno

0350-6134

Povezanost rada

Javno zdravstvo i zdravstvena zaštita

Indeksiranost